Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (1091-1100 of 1,132) with videos related to

Pageof 114
Sort By:
Histopathology|January 27, 2015
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologistsDaniel M Berney, Ferran Algaba, Mahul Amin, et al.
Histopathology|July 25, 2022
Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patientsAndres M Acosta, Ankur R Sangoi, Fiona Maclean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2022
Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American seriesMelissa M Straub Hogan, Andrew J Spieker, Michael Orejudos, et al.
JCO Precision Oncology|May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsMichael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
The Journal of Urology|December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
Histopathology|October 13, 2022
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional seriesKatrina Collins, Lynette M Sholl, Stephanie Siegmund, et al.
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Pageof 114

Showing results (1091-1100 of 1,132) with videos related to

Sort By:
Pageof 114
Histopathology|January 27, 2015
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologistsDaniel M Berney, Ferran Algaba, Mahul Amin, et al.
Histopathology|July 25, 2022
Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patientsAndres M Acosta, Ankur R Sangoi, Fiona Maclean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2022
Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American seriesMelissa M Straub Hogan, Andrew J Spieker, Michael Orejudos, et al.
JCO Precision Oncology|May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsMichael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
The Journal of Urology|December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancerPeter Blume-Jensen, David M Berman, David L Rimm, et al.
Histopathology|October 13, 2022
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional seriesKatrina Collins, Lynette M Sholl, Stephanie Siegmund, et al.
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Pageof 114